SUBINVOLUTION
by: Joanne Bernadette C. Aguilar
Subinvolution
Is the incomplete return of the uterus to its prepregnant size and shape.
Is a medical condition in which after childbirth, the uterus does not return to
its normal size
When the involution is impaired or retarded it is called subinvolution. The
uterus is the most common organ affected by subinvolution. As it is the most
accessible organ to be measured per abdomen, the uterine involution is
considered clinically as an index to assess subinvolution.
Subinvolution may result from a small retained placental fragment, a mild
endometritis(infection of the endometrium),or an accompanying problem such
as a uterine myoma that is interfering with complete contraction
Signs and Symptoms
Symptoms:
The condition may be asymptomatic. The predominant symptoms are:
Abnormal lochial discharge either excessive or prolonged
Irregular or at times excessive uterine bleeding
Irregular cramp like pain is cases of retained products or rise of temperature
in sepsis
Signs:
The uterine height is greater than the normal for the particular day of
puerperium. Normal puerperal uterus may be displaced by a full bladder or a
loaded rectum. It feels boggy and softer upon palpation.
Presence of features responsible for subinvolution may be evident.
Assessment
The uterus is still enlarged and soft
Lochial discharge usually is still present
Causes
- Predisposing factors :
Grand multiparity
Overdistension of uterus as in twins and hydramnios
Ill maternal health
Caesarean section
Uterine prolapse
Retroversion after the uterus becomes pelvic organ
Uterine fibroid
- Aggravating factors
Retained products of conception
Uterine sepsis, endometritis
- Factors
Persistent lochia/fresh bleeding
Long labor
Anesthesia
Full bladder
Difficult delivery
Retained placenta
Maternal infection
Nursing Management
Oral Antibiotics in endometritis
Exploration of the uterus in retained products
Ergometrine so often prescribed to enhance the involution process by
reducing the blood flow of the uterus is of no value in prophylaxis.
Oral administration of methylergonovine 0.2 mg 4 times daily
Administer oxytocin